SKI Market

A+| A| A-|

Indian Indices

Sensex

76,847.57 -702.68
( -0.91%)

Global Indices

Nasdaq

47,930.49 -276.32
(-0.57%)

Dow Jones

6,837.38 -8.28
(-0.12%)

Hang Seng

56,484.90 -439.21
(-0.77%)

Nikkei 225

10,596.33 -7.15
(-0.07%)

Forex

USD-INR

92.50 0.06
(0.07%)

EUR-INR

108.05 0.09
(0.08%)

GBP-INR

124.08 0.03
(0.03%)

JPY-INR

0.58 0.00
(-0.25%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Unichem Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

506690

INE351A01035

344.14393

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

UNICHEMLAB

111.63

2389.22

EPS(TTM)

Face Value()

Div & Yield %

3.04

Particulars(INCOME)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)
Sales Turnover	139.48	132.48	126.97	126.16	132.95	139.70
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	139.48	132.48	126.97	126.16	132.95	139.70
Other Income	13.94	10.53	9.81	6.33	5.02	1.32
Stock Adjustments	0.00	0.00	0.00	0.00	0.00	0.00
Total Income	153.42	143.01	136.78	132.49	137.97	141.02
EXPENDITURE :
Raw Materials	0.00	0.00	0.00	1.81	0.00	0.00
Power & Fuel Cost	2.24	2.20	2.00	1.24	1.17	1.95
Employee Cost	54.27	50.91	44.22	42.86	45.49	48.02
Other Manufacturing Expenses	2.83	2.95	2.33	3.26	3.07	7.08
Selling & Administrative Expenses	48.27	48.94	49.47	46.39	47.41	39.16
Miscellaneous Expenses	0.01	0.00	0.00	0.00	1.37	0.00
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	107.62	105.00	98.02	95.56	98.50	96.20
Operating Profit	45.79	38.01	38.76	36.93	39.47	44.83
Interest	14.60	11.12	8.69	5.98	7.93	6.66
Gross Profit	31.19	26.89	30.07	30.95	31.54	38.17
Depreciation	11.14	13.24	16.16	17.91	18.49	15.52
Profit Before Tax	20.05	13.65	13.91	13.04	13.05	22.65
Tax	5.00	3.76	4.13	3.59	3.90	4.21
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-0.99	-1.19	-2.65	-2.92	0.57	1.59
Reported Net Profit	16.04	11.08	12.43	12.37	8.59	16.85
Extraordinary Items	0.00	0.00	0.00	0.00	-0.90	0.00
Adjusted Net Profit	16.04	11.08	12.43	12.37	9.49	16.85
Adjustment below Net Profit	0.00	0.00	0.00	0.00	-2.86	0.00
P & L Balance brought forward	158.57	147.49	135.06	122.70	116.97	100.12
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
P & L Balance carried down	174.61	158.57	147.49	135.06	122.70	116.97
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Per Share(Rs)	0.00	0.00	0.00	0.00	0.00	0.00
Earnings Per Share-Unit Curr	1.56	1.18	1.49	1.56	2.32	5.15
Earnings Per Share(Adj)-Unit Curr	1.56	1.18	1.49	1.56	1.16	2.58
Book Value-Unit Curr	41.65	40.27	39.71	38.57	77.11	80.58
Book Value(Adj)-Unit Curr	41.65	40.27	39.71	38.57	38.56	40.29

76,847.57 -702.68 ( -0.91%)

47,930.49 -276.32 (-0.57%)

6,837.38 -8.28 (-0.12%)

56,484.90 -439.21 (-0.77%)

10,596.33 -7.15 (-0.07%)

92.50 0.06 (0.07%)

108.05 0.09 (0.08%)

124.08 0.03 (0.03%)

0.58 0.00 (-0.25%)